Abstract
Purpose of Review
To provide an up-to-date review of the epidemiology, presentation, diagnosis, and treatment options for conjunctival nevi (CN).
Recent Findings
Around 17.2%-42% of all conjunctival tumors have been found to be CN, which most frequently present in White individuals between the first to early third decade of life, with equal distribution between males and females. CN commonly occur in the interpalpebral bulbar conjunctiva with pigmentation ranging from amelanotic to dark. Diagnosis is typically made through slit lamp examination, visualized by a well circumscribed, variably elevated, variably pigmented, solitary lesion with clear cysts distributed throughout the pigment. In ambiguous cases, anterior segment optical coherence tomography (AS-OCT) can highlight the presence of sub-clinical cysts, whose presence points to a diagnosis of nevus. However, excisional biopsy with histopathology examination is the gold standard for identifying CN.
Summary
CN are benign, variably pigmented lesions. They are the most common of the conjunctival melanocytic tumors. Due to the extremely low risk of transformation to malignant melanoma (MM), CN are usually managed with routine observation and photo documentation.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig6_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig7_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig8_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig9_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs40135-023-00315-w/MediaObjects/40135_2023_315_Fig10_HTML.png)
Similar content being viewed by others
References
Bresler SC, Simon C, Shields CL, McHugh JB, Stagner AM, Patel RM. Conjunctival Melanocytic Lesions. Arch Pathol Lab Med. 2022;146(5):632–46. https://doi.org/10.5858/arpa.2021-0006-RA.
F. F. E. a. K. Sayyad, C. L. (2013) Conjunctival Pigmented Lesions: Diagnosis and Management. EyeNet Magazine. Available: https://www.aao.org/eyenet/article/conjunctival-pigmented-lesions-diagnosis-managemen
Levecq L, De Potter P, Jamart J. Conjunctival nevi clinical features and therapeutic outcomes. Ophthalmology. 2010;117(1):35–40. https://doi.org/10.1016/j.ophtha.2009.06.018.
Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Indian J Ophthalmol. 2019;67(12):1930–48. https://doi.org/10.4103/ijo.IJO_2040_19.
Lee YJ, Lee C, Kim MK, Khwarg SI, Oh JY. Conjunctival pigmented lesion: Clinicopathological analysis of 85 cases in Korean population. Sci Rep. 2019;9(1):18204. https://doi.org/10.1038/s41598-019-54786-8.
Dalvin LA, Salomao DR, Patel SV. Population-based incidence of conjunctival tumours in Olmsted County, Minnesota. Br J Ophthalmol. 2018;102(12):1728–34. https://doi.org/10.1136/bjophthalmol-2017-311530.
Mirzayev I, Gunduz AK, Gunduz OO, OzalpAtes FS, NalciBaytaroglu H. Demographic and clinical features of conjunctival tumours at a tertiary care centre. Clin Exp Optom. 2022;105(7):708–14. https://doi.org/10.1080/08164622.2021.1971048.
Novais GA, Fernandes BF, Belfort RN, Castiglione E, Cheema DP, Burnier MN Jr. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens. Int J Surg Pathol. 2010;18(1):60–3. https://doi.org/10.1177/1066896908319775.
Pellerano F, Gil G, Rosario A, Manon N, Vargas T, Vizcaino G. Survey of 138 Conjunctival Tumors in the Dominican Republic. Ophthalmic Epidemiol. 2020;27(4):278–82. https://doi.org/10.1080/09286586.2020.1730912.
Shields CL, Demirci H, Karatza E, Shields JA. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology. 2004;111(9):1747–54. https://doi.org/10.1016/j.ophtha.2004.02.013.
Shields CL, et al. Conjunctival Tumors in 5002 Cases. Comparative Analysis of Benign Versus Malignant Counterparts. The 2016 James D. Allen Lecture. Am J Ophthalmol. 2017;173:106–33. https://doi.org/10.1016/j.ajo.2016.09.034.
Amoli FA, Heidari AB. Survey of 447 patients with conjunctival neoplastic lesions in Farabi Eye Hospital, Tehran, Iran. Ophthalmic Epidemiol. 2006;13(4):275–9. https://doi.org/10.1080/09286580600801036.
Grossniklaus HE, Green WR, Luckenbach M, Chan CC. Conjunctival lesions in adults. A clinical and histopathologic review. Cornea. 1987;6(2):78–116. https://doi.org/10.1097/00003226-198706020-00002.
Garcia Onrubia L, et al. Spectrum of conjunctival tumours in a Spanish series: A review of 462 cases. Eur J Ophthalmol. 2020;30(6):1403–9. https://doi.org/10.1177/1120672119870736.
McDonnell JM, Mayr AJ, Martin WJ. DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med. 1989;320(22):1442–6. https://doi.org/10.1056/NEJM198906013202202.
Oellers P, Karp CL. Management of pigmented conjunctival lesions. Ocul Surf. 2012;10(4):251–63. https://doi.org/10.1016/j.jtos.2012.08.002.
Shields CL, Fasiuddin AF, Mashayekhi A, Shields JA. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch Ophthalmol. 2004;122(2):167–75. https://doi.org/10.1001/archopht.122.2.167.
Bredow L, Stutzel L, Bohringer D, Gundlach E, Reinhard T, Auw-Haedrich C. Progesterone and estrogen receptors in conjunctival melanoma and nevi. Graefes Arch Clin Exp Ophthalmol. 2014;252(2):359–65. https://doi.org/10.1007/s00417-013-2523-0.
Pache M, Glatz-Krieger K, Sauter G, Meyer P. Expression of sex hormone receptors and cell cycle proteins in melanocytic lesions of the ocular conjunctiva. Graefes Arch Clin Exp Ophthalmol. 2006;244(1):113–7. https://doi.org/10.1007/s00417-005-0035-2.
Liesegang TJ. Pigmented conjunctival and scleral lesions. Mayo Clin Proc. 1994;69(2):151–61. https://doi.org/10.1016/s0025-6196(12)61042-8.
Folberg R, Jakobiec FA, Bernardino VB, Iwamoto T. Benign conjunctival melanocytic lesions. Clinicopathologic features. Ophthalmology. 1989;96(4):436–61. https://doi.org/10.1016/s0161-6420(89)32878-8.
Zembowicz A, Mandal RV, Choopong P. Melanocytic lesions of the conjunctiva. Arch Pathol Lab Med. 2010;134(12):1785–92. https://doi.org/10.5858/2009-0522-RAR.1.
Sayed-Ahmed I, et al. Blue Nevi of the Ocular Surface: Clinical Characteristics, Pathologic Features, and Clinical Course. Ophthalmology. 2018;125(8):1189–98. https://doi.org/10.1016/j.ophtha.2018.02.006.
Zamir E, Mechoulam H, Micera A, Levi-Schaffer F, Pe’er J. Inflamed juvenile conjunctival naevus: clinicopathological characterisation. Br J Ophthalmol. 2002;86(1):28–30. https://doi.org/10.1136/bjo.86.1.28.
Shields CL, et al. Anterior segment optical coherence tomography of conjunctival nevus. Ophthalmology. 2011;118(5):915–9. https://doi.org/10.1016/j.ophtha.2010.09.016.
Vizvari E, Skribek A, Polgar N, Voros A, Sziklai P, Toth-Molnar E. Conjunctival melanocytic naevus: Diagnostic value of anterior segment optical coherence tomography and ultrasound biomicroscopy. PLoS One. 2018;13(2):e0192908. https://doi.org/10.1371/journal.pone.0192908.
Barros Jde N, Lowen MS, Mascaro VL, Andrade TP, Martins MC. Impression cytology features of conjunctival nevi reported as more noticeable. Arq Bras Oftalmol. 2009;72(2):205–10. https://doi.org/10.1590/s0004-27492009000200014.
Clearfield E, Hawkins BS, Kuo IC. Conjunctival Autograft Versus Amniotic Membrane Transplantation for Treatment of Pterygium: Findings From a Cochrane Systematic Review. Am J Ophthalmol. 2017;182:8–17. https://doi.org/10.1016/j.ajo.2017.07.004.
Tananuvat N, Martin T. The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea. 2004;23(5):458–63. https://doi.org/10.1097/01.ico.0000116522.57227.97.
Prajna NV, Devi L, Seeniraj SK, Keenan JD. Conjunctival Autograft Versus Amniotic Membrane Transplantation After Double Pterygium Excision: A Randomized Trial. Cornea. 2016;35(6):823–6. https://doi.org/10.1097/ICO.0000000000000812.
Kheirkhah A, Nazari R, Nikdel M, Ghassemi H, Hashemi H, Behrouz MJ. Postoperative conjunctival inflammation after pterygium surgery with amniotic membrane transplantation versus conjunctival autograft. Am J Ophthalmol. 2011;152(5):733–8. https://doi.org/10.1016/j.ajo.2011.04.013.
Espana EM, Prabhasawat P, Grueterich M, Solomon A, Tseng SC. Amniotic membrane transplantation for reconstruction after excision of large ocular surface neoplasias. Br J Ophthalmol. 2002;86(6):640–5. https://doi.org/10.1136/bjo.86.6.640.
Gerner N, Norregaard JC, Jensen OA, Prause JU. Conjunctival naevi in Denmark 1960–1980. A 21-year follow-up study. Acta Ophthalmol Scand. 1996;74(4):334–7. https://doi.org/10.1111/j.1600-0420.1996.tb00703.x.
Acknowledgements
Current Stem Ophthalmology Reports would like to thank Editor in Chief, Victor Perez, MD, for his review of this manuscript.
Funding
Supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Clinical Sciences R&D (CSRD) I01 CX002015 (Dr. Galor), Biomedical Laboratory R&D (BLRD) Service I01 BX004893 (Dr. Galor), Rehabilitation R&D (RRD) I21 RX003883 (Dr. Galor), Department of Defense Gulf War Illness Research Program (GWIRP) W81XWH-20–1-0579 (Dr. Galor) and Vision Research Program (VRP) W81XWH-20–1-0820 (Dr. Galor), National Eye Institute U01 EY034686 (Dr. Galor), R01EY026174 (Dr. Galor), R61EY032468 (Dr. Galor), NIH Center Core Grant P30EY014801 (institutional) and Research to Prevent Blindness Unrestricted Grant GR004596-1 (institutional).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest. The authors have no relevant financial or non-financial interests to disclose. The manuscript does not contain clinical studies or patient data.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huang, J.J., Locatelli, E.V.T., Chocron, A. et al. Conjunctival Nevus. Curr Ophthalmol Rep 11, 104–112 (2023). https://doi.org/10.1007/s40135-023-00315-w
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40135-023-00315-w